TY - JOUR AU - Tangjitgamol, S. AU - Manusirivithaya, S. AU - Laopaiboon, M. AU - Lumbiganon, P. PY - 2009 DA - 2009// TI - Interval debulking surgery for advanced epithelial ovarian cancer: a Cochrane systematic review JO - Gynecol Oncol VL - 112 UR - https://doi.org/10.1016/j.ygyno.2008.09.041 DO - 10.1016/j.ygyno.2008.09.041 ID - Tangjitgamol2009 ER - TY - JOUR AU - Siegel, R. L. AU - Miller, K. D. AU - Jemal, A. PY - 2017 DA - 2017// TI - Cancer statistics, 2017 JO - CA Cancer J Clin VL - 67 UR - https://doi.org/10.3322/caac.21387 DO - 10.3322/caac.21387 ID - Siegel2017 ER - TY - JOUR AU - Chen, W. AU - Zheng, R. AU - Baade, P. D. AU - Zhang, S. AU - Zeng, H. AU - Bray, F. AU - Jemal, A. AU - Yu, X. Q. AU - He, J. PY - 2016 DA - 2016// TI - Cancer statistics in China, 2015 JO - CA Cancer J Clin VL - 66 UR - https://doi.org/10.3322/caac.21338 DO - 10.3322/caac.21338 ID - Chen2016 ER - TY - JOUR AU - Stratton, M. i. c. h. a. e. l. R. AU - Campbell, P. e. t. e. r. J. AU - Futreal, P. A. n. d. r. e. w. PY - 2009 DA - 2009// TI - The cancer genome JO - Nature VL - 458 UR - https://doi.org/10.1038/nature07943 DO - 10.1038/nature07943 ID - Stratton2009 ER - TY - JOUR AU - Stratton, M. R. PY - 2011 DA - 2011// TI - Exploring the genomes of cancer cells: progress and promise JO - Science VL - 331 UR - https://doi.org/10.1126/science.1204040331/6024/1553 DO - 10.1126/science.1204040331/6024/1553 ID - Stratton2011 ER - TY - JOUR AU - Russo, A. AU - Calo, V. AU - Bruno, L. AU - Rizzo, S. AU - Bazan, V. AU - Fede, G. PY - 2009 DA - 2009// TI - Hereditary ovarian cancer JO - Crit Rev Oncol Hematol VL - 69 UR - https://doi.org/10.1016/j.critrevonc.2008.06.003 DO - 10.1016/j.critrevonc.2008.06.003 ID - Russo2009 ER - TY - JOUR AU - Narod, S. A. AU - Madlensky, L. AU - Bradley, L. AU - Cole, D. AU - Tonin, P. AU - Rosen, B. AU - Risch, H. A. PY - 1994 DA - 1994// TI - Hereditary and familial ovarian cancer in southern Ontario JO - Cancer VL - 74 UR - https://doi.org/3.0.CO;2-Z DO - 3.0.CO;2-Z ID - Narod1994 ER - TY - STD TI - Integrated genomic analyses of ovarian carcinoma. Nature 2011;474:609–15. https://doi.org/10.1038/nature10166 nature10166 [pii]. ID - ref8 ER - TY - STD TI - Kanchi KL, Johnson KJ, Lu C, et al. Integrated analysis of germline and somatic variants in ovarian cancer. Nat Commun 2014;5:3156. https://doi.org/10.1038/ncomms4156 ncomms4156 [pii]. ID - ref9 ER - TY - JOUR AU - Easton, D. F. AU - Bishop, D. T. AU - Ford, D. AU - Crockford, G. P. PY - 1993 DA - 1993// TI - Genetic linkage analysis in familial breast and ovarian cancer: results from 214 families JO - The Breast Cancer Linkage Consortium Am J Hum Genet VL - 52 ID - Easton1993 ER - TY - JOUR AU - Lynch, H. T. AU - Albano, W. A. AU - Lynch, J. F. AU - Lynch, P. M. AU - Campbell, A. PY - 1982 DA - 1982// TI - Surveillance and management of patients at high genetic risk for ovarian carcinoma JO - Obstet Gynecol VL - 59 ID - Lynch1982 ER - TY - JOUR AU - Walsh, T. AU - Casadei, S. AU - Lee, M. K. PY - 2011 DA - 2011// TI - Mutations in 12 genes for inherited ovarian, fallopian tube, and peritoneal carcinoma identified by massively parallel sequencing JO - Proc Natl Acad Sci U S A VL - 108 UR - https://doi.org/10.1073/pnas.1115052108 DO - 10.1073/pnas.1115052108 ID - Walsh2011 ER - TY - STD TI - Alsop K, Fereday S, Meldrum C, et al. BRCA Mutation Frequency and Patterns of Treatment Response in BRCA Mutation-Positive Women With Ovarian Cancer: A Report From the Australian Ovarian Cancer Study Group. J Clin Oncol 2012;30:2654–63. https://doi: JCO.2011.39.8545 [pii] https://doi.org/10.1200/JCO.2011.39.8545 ID - ref13 ER - TY - STD TI - Boyd J. Molecular genetics of hereditary ovarian cancer. Oncology (Williston Park) 1998;12:399–406; discussion 9–10, 13. https://doi:173180 [pii]. ID - ref14 ER - TY - STD TI - Risch HA, McLaughlin JR, Cole DE, et al. Prevalence and penetrance of germline BRCA1 and BRCA2 mutations in a population series of 649 women with ovarian cancer. Am J Hum Genet 2001;68:700–10. https://doi: S0002–9297(07)63109–7 [pii]https://doi.org/10.1086/318787 ID - ref15 ER - TY - JOUR AU - Matloff, E. T. PY - 2000 DA - 2000// TI - The breast surgeon's role in BRCA1 and BRCA2 testing JO - Am J Surg VL - 180 UR - https://doi.org/10.1016/S0002-9610(00)00460-8 DO - 10.1016/S0002-9610(00)00460-8 ID - Matloff2000 ER - TY - STD TI - Meyerson M, Gabriel S, Getz G. Advances in understanding cancer genomes through second-generation sequencing. Nat Rev Genet. 2010;11:685–96. https://doi:nrg2841 [pii]. https://doi.org/10.1038/nrg2841. ID - ref17 ER - TY - JOUR AU - Ku, C. S. AU - Cooper, D. N. AU - Wu, M. AU - Roukos, D. H. AU - Pawitan, Y. AU - Soong, R. AU - Iacopetta, B. PY - 2012 DA - 2012// TI - Gene discovery in familial cancer syndromes by exome sequencing: prospects for the elucidation of familial colorectal cancer type X JO - Mod Pathol VL - 25 UR - https://doi.org/10.1038/modpathol.2012.62 DO - 10.1038/modpathol.2012.62 ID - Ku2012 ER - TY - JOUR AU - Guan, Y. AU - Hu, H. AU - Peng, Y. PY - 2015 DA - 2015// TI - Detection of inherited mutations for hereditary cancer using target enrichment and next generation sequencing JO - Familial Cancer VL - 14 UR - https://doi.org/10.1007/s10689-014-9749-9 DO - 10.1007/s10689-014-9749-9 ID - Guan2015 ER - TY - JOUR AU - Richards, S. AU - Aziz, N. AU - Bale, S. AU - Bick, D. AU - Das, S. AU - Gastier-Foster, J. AU - Grody, W. W. AU - Hegde, M. AU - Lyon, E. AU - Spector, E. AU - Voelkerding, K. AU - Rehm, H. L. PY - 2015 DA - 2015// TI - Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology JO - Genet Med VL - 17 UR - https://doi.org/10.1038/gim.2015.30 DO - 10.1038/gim.2015.30 ID - Richards2015 ER - TY - JOUR AU - Walsh, T. AU - Lee, M. K. AU - Casadei, S. AU - Thornton, A. M. AU - Stray, S. M. AU - Pennil, C. AU - Nord, A. S. AU - Mandell, J. B. AU - Swisher, E. M. AU - King, M. C. PY - 2010 DA - 2010// TI - Detection of inherited mutations for breast and ovarian cancer using genomic capture and massively parallel sequencing JO - Proc Natl Acad Sci U S A VL - 107 UR - https://doi.org/10.1073/pnas.10079831071007983107 DO - 10.1073/pnas.10079831071007983107 ID - Walsh2010 ER - TY - JOUR AU - Wu, X. AU - Wu, L. AU - Kong, B. PY - 2017 DA - 2017// TI - The first Nationwide multicenter prevalence study of germline BRCA1 and BRCA2 mutations in Chinese ovarian Cancer patients JO - Int J Gynecol Cancer VL - 27 UR - https://doi.org/10.1097/IGC.0000000000001065 DO - 10.1097/IGC.0000000000001065 ID - Wu2017 ER - TY - JOUR AU - Boyd, J. AU - Sonoda, Y. AU - Federici, M. G. PY - 2000 DA - 2000// TI - Clinicopathologic features of BRCA-linked and sporadic ovarian cancer JO - JAMA VL - 283 UR - https://doi.org/10.1001/jama.283.17.2260 DO - 10.1001/jama.283.17.2260 ID - Boyd2000 ER - TY - JOUR AU - Janavicius, R. AU - Rudaitis, V. AU - Mickys, U. AU - Elsakov, P. AU - Griskevicius, L. PY - 2014 DA - 2014// TI - Comprehensive BRCA1 and BRCA2 mutational profile in Lithuania JO - Cancer Genet VL - 207 UR - https://doi.org/10.1016/j.cancergen.2014.05.002 DO - 10.1016/j.cancergen.2014.05.002 ID - Janavicius2014 ER - TY - STD TI - Lee JS, John EM, McGuire V, Felberg A, Ostrow KL, DiCioccio RA, Li FP, Miron A, West DW, Whittemore AS. Breast and ovarian cancer in relatives of cancer patients, with and without BRCA mutations. Cancer Epidemiol Biomark Prev. 2006;15:359–63. https://doi:15/2/359 [pii]. https://doi.org/10.1158/1055-9965.EPI-05-0687. ID - ref25 ER - TY - STD TI - Liede A, Malik IA, Aziz Z, Rios Pd Pde L, Kwan E, Narod SA. Contribution of BRCA1 and BRCA2 mutations to breast and ovarian cancer in Pakistan. Am J Hum Genet 2002;71:595–606. https://doi: S0002-9297(07)60339-5 [pii]. ID - ref26 ER - TY - JOUR AU - Lim, M. C. AU - Kang, S. AU - Seo, S. S. AU - Kong, S. Y. AU - Lee, B. Y. AU - Lee, S. K. AU - Park, S. Y. PY - 2009 DA - 2009// TI - BRCA1 and BRCA2 germline mutations in Korean ovarian cancer patients JO - J Cancer Res Clin Oncol VL - 135 UR - https://doi.org/10.1007/s00432-009-0607-3 DO - 10.1007/s00432-009-0607-3 ID - Lim2009 ER - TY - JOUR AU - Menkiszak, J. AU - Gronwald, J. AU - Gorski, B. PY - 2003 DA - 2003// TI - Hereditary ovarian cancer in Poland JO - Int J Cancer VL - 106 UR - https://doi.org/10.1002/ijc.11338 DO - 10.1002/ijc.11338 ID - Menkiszak2003 ER - TY - JOUR AU - Modan, B. AU - Hartge, P. AU - Hirsh-Yechezkel, G. AU - Chetrit, A. AU - Lubin, F. AU - Beller, U. AU - Ben-Baruch, G. AU - Fishman, A. AU - Menczer, J. AU - Struewing, J. P. AU - Tucker, M. A. AU - Wacholder, S. PY - 2001 DA - 2001// TI - Parity, oral contraceptives, and the risk of ovarian cancer among carriers and noncarriers of a BRCA1 or BRCA2 mutation JO - N Engl J Med VL - 345 UR - https://doi.org/10.1056/nejm200107263450401 DO - 10.1056/nejm200107263450401 ID - Modan2001 ER - TY - JOUR AU - Pal, T. AU - Permuth-Wey, J. AU - Betts, J. A. PY - 2005 DA - 2005// TI - BRCA1 and BRCA2 mutations account for a large proportion of ovarian carcinoma cases JO - Cancer VL - 104 UR - https://doi.org/10.1002/cncr.21536 DO - 10.1002/cncr.21536 ID - Pal2005 ER - TY - STD TI - Risch HA, McLaughlin JR, Cole DE, Rosen B, Bradley L, Fan I, Tang J, Li S, Zhang S, Shaw PA, Narod SA. Population BRCA1 and BRCA2 mutation frequencies and cancer penetrances: a kin-cohort study in Ontario, Canada. J Natl Cancer Inst. 2006;98:1694–706. https://doi:98/23/1694 [pii]. https://doi.org/10.1093/jnci/djj465. ID - ref31 ER - TY - JOUR AU - Rodriguez, A. O. AU - Llacuachaqui, M. AU - Pardo, G. G. AU - Royer, R. AU - Larson, G. AU - Weitzel, J. N. AU - Narod, S. A. PY - 2012 DA - 2012// TI - BRCA1 and BRCA2 mutations among ovarian cancer patients from Colombia JO - Gynecol Oncol VL - 124 UR - https://doi.org/10.1016/j.ygyno.2011.10.027 DO - 10.1016/j.ygyno.2011.10.027 ID - Rodriguez2012 ER - TY - JOUR AU - Sakamoto, I. AU - Hirotsu, Y. AU - Nakagomi, H. AU - Ouchi, H. AU - Ikegami, A. AU - Teramoto, K. AU - Amemiya, K. AU - Mochizuki, H. AU - Omata, M. PY - 2016 DA - 2016// TI - BRCA1 and BRCA2 mutations in Japanese patients with ovarian, fallopian tube, and primary peritoneal cancer JO - Cancer VL - 122 UR - https://doi.org/10.1002/cncr.29707 DO - 10.1002/cncr.29707 ID - Sakamoto2016 ER - TY - JOUR AU - Sarantaus, L. AU - Vahteristo, P. AU - Bloom, E. AU - Tamminen, A. AU - Unkila-Kallio, L. AU - Butzow, R. AU - Nevanlinna, H. PY - 2001 DA - 2001// TI - BRCA1 and BRCA2 mutations among 233 unselected Finnish ovarian carcinoma patients JO - Eur J Hum Genet VL - 9 UR - https://doi.org/10.1038/sj.ejhg.5200652 DO - 10.1038/sj.ejhg.5200652 ID - Sarantaus2001 ER - TY - JOUR AU - Stavropoulou, A. V. AU - Fostira, F. AU - Pertesi, M. PY - 2013 DA - 2013// TI - Prevalence of BRCA1 mutations in familial and sporadic greek ovarian cancer cases JO - PLoS One VL - 8 UR - https://doi.org/10.1371/journal.pone.0058182 DO - 10.1371/journal.pone.0058182 ID - Stavropoulou2013 ER - TY - JOUR AU - Tobias, D. H. AU - Eng, C. AU - McCurdy, L. D. AU - Kalir, T. AU - Mandelli, J. AU - Dottino, P. R. AU - Cohen, C. J. PY - 2000 DA - 2000// TI - Founder BRCA 1 and 2 mutations among a consecutive series of Ashkenazi Jewish ovarian cancer patients JO - Gynecol Oncol VL - 78 UR - https://doi.org/10.1006/gyno.2000.5848 DO - 10.1006/gyno.2000.5848 ID - Tobias2000 ER - TY - JOUR AU - Tonin, P. N. AU - Mes-Masson, A. M. AU - Narod, S. A. AU - Ghadirian, P. AU - Provencher, D. PY - 1999 DA - 1999// TI - Founder BRCA1 and BRCA2 mutations in French Canadian ovarian cancer cases unselected for family history JO - Clin Genet VL - 55 UR - https://doi.org/10.1034/j.1399-0004.1999.550504.x DO - 10.1034/j.1399-0004.1999.550504.x ID - Tonin1999 ER - TY - JOUR AU - Looij, M. AU - Szabo, C. AU - Besznyak, I. AU - Liszka, G. AU - Csokay, B. AU - Pulay, T. AU - Toth, J. AU - Devilee, P. AU - King, M. C. AU - Olah, E. PY - 2000 DA - 2000// TI - Prevalence of founder BRCA1 and BRCA2 mutations among breast and ovarian cancer patients in Hungary JO - Int J Cancer VL - 86 UR - https://doi.org/3.0.CO;2-1 DO - 3.0.CO;2-1 ID - Looij2000 ER - TY - JOUR AU - Zhang, S. AU - Royer, R. AU - Li, S. AU - McLaughlin, J. R. AU - Rosen, B. AU - Risch, H. A. AU - Fan, I. AU - Bradley, L. AU - Shaw, P. A. AU - Narod, S. A. PY - 2011 DA - 2011// TI - Frequencies of BRCA1 and BRCA2 mutations among 1,342 unselected patients with invasive ovarian cancer JO - Gynecol Oncol VL - 121 UR - https://doi.org/10.1016/j.ygyno.2011.01.020 DO - 10.1016/j.ygyno.2011.01.020 ID - Zhang2011 ER - TY - STD TI - SGO Clinical Practice Statement: Next generation Cancer gene panels versus gene by gene testing. Mar 2014. https://www.sgo.org/clinical-practice/guidelines/next-generation-cancer-gene-panels-versus-gene-by-gene-testing/. UR - https://www.sgo.org/clinical-practice/guidelines/next-generation-cancer-gene-panels-versus-gene-by-gene-testing/ ID - ref40 ER - TY - STD TI - NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines®). Genetic/Familial High-Risk Assessment: Breast and Ovarian. Version 2.2019 - July 30, 2018. https://www.nccn.org/professionals/physician_gls/pdf/genetics_screening.pdf. UR - https://www.nccn.org/professionals/physician_gls/pdf/genetics_screening.pdf ID - ref41 ER - TY - JOUR AU - Brosh, R. AU - Rotter, V. PY - 2009 DA - 2009// TI - When mutants gain new powers: news from the mutant p53 field JO - Nat Rev Cancer VL - 9 UR - https://doi.org/10.1038/nrc2693 DO - 10.1038/nrc2693 ID - Brosh2009 ER - TY - JOUR AU - Despierre, E. AU - Lambrechts, D. AU - Neven, P. AU - Amant, F. AU - Lambrechts, S. AU - Vergote, I. PY - 2010 DA - 2010// TI - The molecular genetic basis of ovarian cancer and its roadmap towards a better treatment JO - Gynecol Oncol VL - 117 UR - https://doi.org/10.1016/j.ygyno.2010.02.012 DO - 10.1016/j.ygyno.2010.02.012 ID - Despierre2010 ER - TY - JOUR AU - Delgado-Ortega, L. AU - Gines Rubio, J. AU - Garcias de Espana, M. D. C. AU - Carcedo, D. AU - Cordero Puentes, L. AU - Moya de Alarcon, C. PY - 2018 DA - 2018// TI - Economic impact of olaparib on maintenance treatment of patients with BRCA-mutation positive, platinum-sensitive relapsing high-grade serous epithelial ovarian cancer in Spain JO - Farm Hosp VL - 42 UR - https://doi.org/10.7399/fh.10904 DO - 10.7399/fh.10904 ID - Delgado-Ortega2018 ER - TY - JOUR AU - McLachlan, J. AU - Banerjee, S. PY - 2016 DA - 2016// TI - Olaparib for the treatment of epithelial ovarian cancer JO - Expert Opin Pharmacother VL - 17 UR - https://doi.org/10.1517/14656566.2016.1165205 DO - 10.1517/14656566.2016.1165205 ID - McLachlan2016 ER - TY - JOUR AU - Pennington, K. a. t. h. r. y. n. P. AU - Walsh, T. o. m. AU - Harrell, M. a. r. i. a. I. AU - Lee, M. i. n. g. K. AU - Pennil, C. h. r. i. s. t. o. p. h. e. r. C. AU - Rendi, M. a. r. a. H. AU - Thornton, A. n. n. e. AU - Norquist, B. a. r. b. a. r. a. M. AU - Casadei, S. i. l. v. i. a. AU - Nord, A. l. e. x. a. n. d. e. r. S. AU - Agnew, K. a. t. h. y. J. AU - Pritchard, C. o. l. i. n. C. AU - Scroggins, S. h. e. e. n. a. AU - Garcia, R. o. c. h. e. l. l. e. L. AU - King, M. a. r. y. -. C. l. a. i. r. e. AU - Swisher, E. l. i. z. a. b. e. t. h. M. PY - 2013 DA - 2013// TI - Germline and Somatic Mutations in Homologous Recombination Genes Predict Platinum Response and Survival in Ovarian, Fallopian Tube, and Peritoneal Carcinomas JO - Clinical Cancer Research VL - 20 UR - https://doi.org/10.1158/1078-0432.CCR-13-2287 DO - 10.1158/1078-0432.CCR-13-2287 ID - Pennington2013 ER - TY - JOUR AU - Manchanda, R. AU - Legood, R. AU - Antoniou, A. C. AU - Gordeev, V. S. AU - Menon, U. PY - 2016 DA - 2016// TI - Specifying the ovarian cancer risk threshold of 'premenopausal risk-reducing salpingo-oophorectomy' for ovarian cancer prevention: a cost-effectiveness analysis JO - J Med Genet VL - 53 UR - https://doi.org/10.1136/jmedgenet-2016-103800 DO - 10.1136/jmedgenet-2016-103800 ID - Manchanda2016 ER - TY - JOUR AU - Cass, I. AU - Baldwin, R. L. AU - Varkey, T. AU - Moslehi, R. AU - Narod, S. A. AU - Karlan, B. Y. PY - 2003 DA - 2003// TI - Improved survival in women with BRCA-associated ovarian carcinoma JO - Cancer VL - 97 UR - https://doi.org/10.1002/cncr.11310 DO - 10.1002/cncr.11310 ID - Cass2003 ER - TY - JOUR AU - Chetrit, A. AU - Hirsh-Yechezkel, G. AU - Ben-David, Y. AU - Lubin, F. AU - Friedman, E. AU - Sadetzki, S. PY - 2008 DA - 2008// TI - Effect of BRCA1/2 mutations on long-term survival of patients with invasive ovarian Cancer: the National Israeli Study of ovarian Cancer JO - J Clin Oncol VL - 26 UR - https://doi.org/10.1200/jco.2007.11.6905 DO - 10.1200/jco.2007.11.6905 ID - Chetrit2008 ER - TY - JOUR AU - Tan, D. S. AU - Rothermundt, C. AU - Thomas, K. AU - Bancroft, E. AU - Eeles, R. AU - Shanley, S. AU - Ardern-Jones, A. AU - Norman, A. AU - Kaye, S. B. AU - Gore, M. E. PY - 2008 DA - 2008// TI - "BRCAness" syndrome in ovarian cancer: a case-control study describing the clinical features and outcome of patients with epithelial ovarian cancer associated with BRCA1 and BRCA2 mutations JO - J Clin Oncol VL - 26 UR - https://doi.org/10.1200/jco.2008.16.1703 DO - 10.1200/jco.2008.16.1703 ID - Tan2008 ER - TY - JOUR AU - Bolton, K. L. AU - Chenevix-Trench, G. AU - Goh, C. PY - 2012 DA - 2012// TI - Association between BRCA1 and BRCA2 mutations and survival in women with invasive epithelial ovarian cancer JO - JAMA VL - 307 UR - https://doi.org/10.1001/jama.2012.20 DO - 10.1001/jama.2012.20 ID - Bolton2012 ER - TY - JOUR AU - Dong, F. AU - Davineni, P. K. AU - Howitt, B. E. AU - Beck, A. H. PY - 2016 DA - 2016// TI - A BRCA1/2 mutational signature and survival in ovarian high-grade serous carcinoma JO - Cancer Epidemiol Biomark Prev VL - 25 UR - https://doi.org/10.1158/1055-9965.epi-16-0286 DO - 10.1158/1055-9965.epi-16-0286 ID - Dong2016 ER -